Brief: Ultimovacs Receives Intention To Grant Notice On European Patent
13/04/2023 10:43
April 13 (Reuters) - Ultimovacs ASA ULTI.OL :
* RECEIVES NOTICE OF INTENTION TO GRANT FROM EUROPEAN PATENT
OFFICE CONCERNING APPLICATION ON USE OF VACCINE-CHECKPOINT
INHIBITOR COMBINATIONS TO TREAT CANCER
Source text for Eikon: ID:nGNE2fpDFQ
Further company coverage: ULTI.OL
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))
Recent news on Zelluna ASA
See all newsNorway's Zelluna ASA reports Q2 loss
Brief: Zelluna Reports Q2 Total Loss Of NOK 19.7 Million
Brief: Zelluna Says IDMC Recommends Recruitment Of Next Two Patients At First Dose Level
Brief: Zelluna Says First Patient Dosed With Zi-Ma4-1 In Zima-101 Phase 1 Trial
Brief: Zelluna Wins NOK 16 Mln Research Council Of Norway Grant